Drug Information

Drug General Information
Drug ID
D0T7DV
Former ID
DNC013260
Drug Name
SODIUM ZINC DIHYDROLIPOYLHISTIDINATE
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528613]
Structure
Download
2D MOL

3D MOL
Formula
C14H20N3NaO3S2Zn
Canonical SMILES
C1=C(NC=N1)CC(C(=O)[O-])NC(=O)CCCCC(CC[S-])[S-].[Na+].[<br />Zn+2]
InChI
1S/C14H23N3O3S2.Na.Zn/c18-13(4-2-1-3-11(22)5-6-21)17-12(14(19)20)7-10-8-15-9-16-10;;/h8-9,11-12,21-22H,1-7H2,(H,15,16)(H,17,18)(H,19,20);;/q;+1;+2/p-3
InChIKey
GLGKCICLFLDJDO-UHFFFAOYSA-K
PubChem Compound ID
44423423
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [528613]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 528613Bioorg Med Chem. 2007 Mar 1;15(5):1967-75. Epub 2006 Dec 31.Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.
Ref 528613Bioorg Med Chem. 2007 Mar 1;15(5):1967-75. Epub 2006 Dec 31.Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.